The evolution of bispecific antibodies

Expert Opin Biol Ther. 2022 Aug;22(8):945-949. doi: 10.1080/14712598.2022.2040987. Epub 2022 Feb 21.

Author

Affiliation

¹ Mythic Therapeutics Inc, Waltham, MA, USA.

PMID: 35147061
DOI: 10.1080/14712598.2022.2040987

No abstract available

Keywords: Antibodies; antibody engineering; bispecific antibodies; developability; formats.

Publication types

Editorial

MeSH terms

Antibodies, Bispecific* / therapeutic use
Humans
Immunotherapy
Protein Engineering
Single-Chain Antibodies*

Substances

Antibodies, Bispecific
Single-Chain Antibodies